Hecto Healthcare launches 'De Simone Capsule Premium' with 100 billion CFU per capsule
- Input
- 2026-09-28 08:19:50
- Updated
- 2026-09-28 08:19:50
Hecto Healthcare announced on the 28th that it will officially launch 'De Simone Capsule Premium' on October 12. Ahead of the official launch, the company will begin a presale of 1,000 units on the same day, offering discounts of up to 40% during the presale period. Products will be shipped sequentially after the official launch date.
The new product is designed to be taken as one capsule a day. With the launch, Hecto Healthcare also plans to strengthen its direct-to-consumer (D2C) strategy through its own online store. The company aims to expand consumer engagement by providing product information directly through its official mall and offering presales and limited-time benefits.
'De Simone Capsule Premium' uses DSF (De Simone Formulation), an ingredient developed by Claudio De Simone, a renowned global researcher in probiotics.
DSF is a complex probiotic ingredient made by combining eight types of lactic acid bacteria. Research on the ingredient has been accumulated through 469 international academic papers, including articles published in SCI-indexed journals, and it holds patents in 15 countries worldwide. It is sold in 40 countries, including the United States and European countries.
In South Korea, it received individual recognition from the Ministry of Food and Drug Safety in 2009 for the functionality of 'helping support intestinal health by regulating intestinal immunity.'
Kim Seok-jin, CEO of Hecto Healthcare, said, "De Simone Capsule Premium is designed to guarantee 100 billion CFU of probiotics per capsule while allowing consumers to conveniently take one capsule a day." He added, "We will continue expanding our product line based on our research achievements and technological capabilities, taking into account consumers' health-management needs and convenience of use."
[email protected] Jeong Sang-hee Reporter